Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eμ-TCL1 transgenic mice

被引:0
|
作者
Collard, James P. [1 ,2 ]
McKenna, Mary K. [1 ,2 ]
Noothi, Sunil K. [1 ,2 ]
Alhakeem, Sara S. [1 ,2 ]
Rivas, Jacqueline R. [1 ,2 ]
Rangnekar, Vivek M. [2 ,3 ]
Muthusamy, Natarajan [4 ]
Bondada, Subbarao [1 ,2 ]
机构
[1] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA
[2] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
[3] Univ Kentucky, Dept Radiat Med, Lexington, KY USA
[4] Ohio State Univ, James Canc Ctr, Div Hematol, Columbus, OH USA
基金
美国国家卫生研究院;
关键词
Cell lines and animal models; lymphoid leukemia; cytokine production and paraneoplastic conditions; basic biology; lymphocytes; MOUSE MODEL; CELLS; DISEASE; TCL1; PROGRESSION; ACTIVATION; PATHWAY; BETA; CLL; LEUKEMOGENESIS;
D O I
10.1080/10428194.2022.2045596
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The chronic lymphocytic leukemia (CLL) microenvironment has been receiving an increasing amount of attention, but there is currently limited data surrounding how the microenvironment affects initial development of CLL. We determined that the spleen is the initial site of CLL growth through monitoring of transgenic E mu-TCL1 mice that develop CLL. Subsequently, we isolated stromal cells from the spleens of E mu-TCL1 mice (EMST cells) that induce CLL cell division in vitro. Both cell-cell contact and soluble factors were involved in EMST-induced CLL cell division. These stromal cells are present in significantly larger numbers in the spleen than other lymphoid organs. We also noted that splenectomy delayed CLL development in E mu-TCL1 mice and completely prevented CLL development in adoptive transfer mice. Our findings will allow future studies surrounding the CLL microenvironment to focus upon the splenic stromal cells.
引用
收藏
页码:1810 / 1822
页数:13
相关论文
共 50 条
  • [1] BAFF accelerates development of chronic lymphocytic leukemia in TCL1 transgenic mice
    Enzler, Thomas
    Widhopf, George F.
    Lee, Jason
    Zhang, Weizhou
    Croce, Carlo M.
    Karin, Michael
    Kipps, Thomas J.
    BLOOD, 2007, 110 (11) : 339A - 339A
  • [2] Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Eμ-TCL1 transgenic mice
    Zanesi, N
    Aqeilan, R
    Drusco, A
    Kaou, M
    Sevignani, C
    Costinean, S
    Bortesi, L
    La Rocca, G
    Koldovsky, P
    Volinia, S
    Mancini, R
    Calin, G
    Scott, CP
    Pekarsky, Y
    Croce, CM
    CANCER RESEARCH, 2006, 66 (02) : 915 - 920
  • [3] CD74 is dispensable for development of chronic lymphocytic leukemia inEμ-TCL1 transgenic mice
    Barthel, Romy
    Fedorchenko, Oleg
    Velmans, Tanja
    Rosen, Natascha
    Phuong-Hien Nguyen
    Reinart, Nina
    Florin, Alexandra
    Herling, Marco
    Hallek, Michael
    Fingerle-Rowson, Guenter
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2799 - 2810
  • [4] TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
    Eva Szenes
    Andrea Härzschel
    Sarah Decker
    Erika Tissino
    Justine Pischeli
    Julia Christine Gutjahr
    Sandra Kissel
    Sandra Pennisi
    Jan Philip Höpner
    Alexander Egle
    Nadja Zaborsky
    Christine Dierks
    Marie Follo
    Alexandre Chigaev
    Antonella Zucchetto
    Richard Greil
    Valter Gattei
    Tanja Nicole Hartmann
    Leukemia, 2020, 34 : 2498 - 2502
  • [5] TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
    Szenes, Eva
    Haerzschel, Andrea
    Decker, Sarah
    Tissino, Erika
    Pischeli, Justine
    Gutjahr, Julia Christine
    Kissel, Sandra
    Pennisi, Sandra
    Hoepner, Jan Philip
    Egle, Alexander
    Zaborsky, Nadja
    Dierks, Christine
    Follo, Marie
    Chigaev, Alexandre
    Zucchetto, Antonella
    Greil, Richard
    Gattei, Valter
    Hartmann, Tanja Nicole
    LEUKEMIA, 2020, 34 (09) : 2498 - 2502
  • [6] TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
    Hartmann, T. N.
    Szenes, E.
    Polcik, L.
    Decker, S.
    Haslauer, T.
    Pischeli, J.
    Kissel, S.
    Hoepner, J. P.
    Egle, A.
    Zaborsky, N.
    Dierks, C.
    Greil, R.
    Gattei, V
    Haerzschel, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 70 - 70
  • [7] The TCL1 mouse as a model for chronic lymphocytic leukemia
    Hamblin, Terry J.
    LEUKEMIA RESEARCH, 2010, 34 (02) : 135 - 136
  • [8] PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia
    Holler, Claudia
    Pinon, Josefina D.
    Denk, Ursula
    Heyder, Christoph
    Hofbauer, Sebastian
    Greil, Richard
    Egle, Alexander
    BLOOD, 2009, 113 (12) : 2791 - 2794
  • [9] Expression of ZAP-70 Does Not Accelerate Leukemia Development and Progression in the Eμ-TCL1 Transgenic Mouse Model of Chronic Lymphocytic Leukemia
    Gobessi, Stefania
    Belfiore, Francesca
    Bennardo, Sara
    Doe, Brendan
    Laurenti, Luca
    Efremov, Dimitar G.
    BLOOD, 2012, 120 (21)
  • [10] The role of the splenic microenvironment in Chronic Lymphocytic Leukemia
    Bondada, Subbarao
    Collard, James P.
    McKenna, Mary Kathryn
    Noothi, Sunil K.
    Alhakeem, Sara S.
    Rivas, Jacqueline R.
    Broeking, Shelbi
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):